CoChat

The HLA-II immunopeptidome of SARS-CoV-2

Weingarten-Gabbay, Shira, Chen, Da-Yuan, Sarkizova, Siranush, Taylor, Hannah B., Gentili, Matteo, Hernandez, Gabrielle M., Pearlman, Leah R., Bauer, Matthew R., Rice, Charles M., Clauser, Karl R., Hacohen, Nir, Carr, Steven A., Abelin, Jennifer G., Saeed, Mohsan, Sabeti, Pardis C. · 2024 · Cell Reports

Published version of a preprint

Cited by 17

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2023.113596

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Wherry, 2022, T cell immunity to COVID-19 vaccines, Science, 377, 821, 10.1126/science.add2897 · DOI · Paper page
  2. Pardi, 2018, mRNA vaccines — a new era in vaccinology, Nat. Rev. Drug Discov., 17, 261, 10.1038/nrd.2017.243 · DOI · Paper page
  3. Neale, 2023, CD4+ and CD8+ T Cell and Antibody Correlates of Protection against Delta Vaccine Breakthrough Infection: A Nested Case-Control Study within the PITCH Study, medRxiv
  4. Martínez-Flores, 2021, SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants, Front. Immunol., 12, 701501, 10.3389/fimmu.2021.701501 · DOI · Paper page
  5. Oronsky, 2022, Nucleocapsid as a next-generation COVID-19 vaccine candidate, Int. J. Infect. Dis., 122, 529, 10.1016/j.ijid.2022.06.046 · DOI
  6. Dutta, 2020, The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development, J. Virol., 94, e00647-20, 10.1128/JVI.00647-20 · DOI · Paper page
  7. Arieta, 2023, The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection, Cell, 186, 2392, 10.1016/j.cell.2023.04.007 · DOI · Paper page
  8. Matchett, 2021, Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity, J. Immunol., 207, 376, 10.4049/jimmunol.2100421 · DOI · Paper page
  9. Chen, 2021, T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research, J. Cell Mol. Med., 25, 1274, 10.1111/jcmm.16200 · DOI
  10. Keller, 2020, SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein, Blood, 136, 2905, 10.1182/blood.2020008488 · DOI · Paper page
  11. Joag, 2021, Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses, J. Immunol., 206, 931, 10.4049/jimmunol.2001400 · DOI
  12. Lee, 2021, Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity, J. Virol., 95, 10.1128/JVI.02002-20 · DOI
  13. Mahajan, 2021, Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals, Sci. Rep., 11, 10.1038/s41598-021-92521-4 · DOI
  14. Nielsen, 2021, SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity, EBioMedicine, 68, 10.1016/j.ebiom.2021.103410 · DOI
  15. Rha, 2021, PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19, Immunity, 54, 44, 10.1016/j.immuni.2020.12.002 · DOI · Paper page
  16. Shomuradova, 2020, SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors, Immunity, 53, 1245, 10.1016/j.immuni.2020.11.004 · DOI · Paper page
  17. Ferretti, 2020, Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein, Immunity, 53, 1095, 10.1016/j.immuni.2020.10.006 · DOI · Paper page
  18. Kared, 2021, SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals, J. Clin. Invest., 131, 10.1172/JCI145476 · DOI · Paper page
  19. Prakash, 2021, Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines, J. Immunol., 206, 2566, 10.4049/jimmunol.2001438 · DOI · Paper page
  20. Finkel, 2020, The Coding Capacity of SARS-CoV-2, bioRxiv
  21. Abelin, 2017, Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction, Immunity, 46, 315, 10.1016/j.immuni.2017.02.007 · DOI · Paper page
  22. Bassani-Sternberg, 2016, Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions, J. Immunol., 197, 2492, 10.4049/jimmunol.1600808 · DOI · Paper page
  23. Chong, 2018, High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome, Mol. Cell. Proteomics, 17, 533, 10.1074/mcp.TIR117.000383 · DOI · Paper page
  24. Sarkizova, 2020, A large peptidome dataset improves HLA class I epitope prediction across most of the human population, Nat. Biotechnol., 38, 199, 10.1038/s41587-019-0322-9 · DOI · Paper page
  25. Croft, 2013, Kinetics of antigen expression and epitope presentation during virus infection, PLoS Pathog., 9, 10.1371/journal.ppat.1003129 · DOI · Paper page
  26. McMurtrey, 2008, Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes, Proc. Natl. Acad. Sci. USA, 105, 2981, 10.1073/pnas.0711874105 · DOI
  27. Rucevic, 2016, Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses, J. Virol., 90, 8605, 10.1128/JVI.00599-16 · DOI
  28. Schellens, 2015, Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation, Front. Immunol., 6, 546, 10.3389/fimmu.2015.00546 · DOI
  29. Ternette, 2016, Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells, Eur. J. Immunol., 46, 60, 10.1002/eji.201545890 · DOI · Paper page
  30. Nagler, 2021, Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics, Cell Rep., 35, 10.1016/j.celrep.2021.109305 · DOI · Paper page
  31. Knierman, 2020, The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein, Cell Rep., 33, 10.1016/j.celrep.2020.108454 · DOI · Paper page
  32. Parker, 2021, Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells, Cell Rep., 35, 10.1016/j.celrep.2021.109179 · DOI · Paper page
  33. Becerra-Artiles, 2022, Immunopeptidome Profiling of Human Coronavirus OC43-Infected Cells Identifies CD4 T Cell Epitopes Specific to Seasonal Coronaviruses or Cross-Reactive with SARS-CoV-2, bioRxiv
  34. Becerra-Artiles, 2019, Naturally processed HLA-DR3-restricted HHV-6B peptides are recognized broadly with polyfunctional and cytotoxic CD4 T-cell responses, Eur. J. Immunol., 49, 1167, 10.1002/eji.201948126 · DOI
  35. Forlani, 2021, CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens, Mol. Cell. Proteomics, 20, 10.1074/mcp.RA120.002201 · DOI
  36. Hos, 2022, Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA, Cell Rep., 41, 10.1016/j.celrep.2022.111485 · DOI
  37. Neuwelt, 2020, Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms, J. Immunother. Cancer, 8
  38. Wosen, 2018, Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts, Front. Immunol., 9, 2144, 10.3389/fimmu.2018.02144 · DOI · Paper page
  39. Andreatta, 2017, GibbsCluster: unsupervised clustering and alignment of peptide sequences, Nucleic Acids Res., 45, W458, 10.1093/nar/gkx248 · DOI · Paper page
  40. Deffrennes, 2001, Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter, J. Immunol., 167, 98, 10.4049/jimmunol.167.1.98 · DOI
  41. Bruchez, 2020, MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses, Science, 370, 241, 10.1126/science.abb3753 · DOI
  42. Ovsyannikova, 2003, Naturally processed measles virus peptide eluted from class II HLA-DRB1∗03 recognized by T lymphocytes from human blood, Virology, 312, 495, 10.1016/S0042-6822(03)00281-2 · doi:10.1016/s0042-6822(03)00281-2
  43. Cassotta, 2020, Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin, J. Exp. Med., 217, 10.1084/jem.20200206 · DOI
  44. Abelin, 2019, Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction, Immunity, 51, 766, 10.1016/j.immuni.2019.08.012 · DOI · Paper page
  45. Taylor, 2021, MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies, Mol. Cell. Proteomics, 20, 10.1016/j.mcpro.2021.100116 · DOI
  46. Lippolis, 2002, Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets, J. Immunol., 169, 5089, 10.4049/jimmunol.169.9.5089 · DOI · Paper page
  47. Firth, 2020, A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a, J. Gen. Virol., 101, 1085, 10.1099/jgv.0.001469 · DOI
  48. Jungreis, 2021, SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes, Nat. Commun., 12, 2642, 10.1038/s41467-021-22905-7 · DOI · Paper page
  49. Cagliani, 2020, Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses, Infect. Genet. Evol., 83, 10.1016/j.meegid.2020.104353 · DOI
  50. Prakash, S., Srivastava, R., Coulon, P.-G., Dhanushkodi, N.R., Chentoufi, A.A., Tifrea, D.F., Edwards, R.A., Figueroa, C., Schubl, S.D., Hsieh, L., et al. Genome-Wide Asymptomatic B-Cell, CD4 and CD8 T-Cell Epitopes, that are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Immune Targets for Pre-Emptive Pan-Coronavirus Vaccines. SSRN Journal. .
  51. Kyriakidis, 2021, SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates, NPJ Vaccines, 6, 28, 10.1038/s41541-021-00292-w · DOI · Paper page
  52. Creech, 2021, SARS-CoV-2 Vaccines, JAMA, 325, 1318, 10.1001/jama.2021.3199 · DOI · Paper page
  53. Barouch, 2022, Covid-19 Vaccines — Immunity, Variants, Boosters, N. Engl. J. Med., 387, 1011, 10.1056/NEJMra2206573 · DOI · Paper page
  54. Dai, 2021, Viral targets for vaccines against COVID-19, Nat. Rev. Immunol., 21, 73, 10.1038/s41577-020-00480-0 · DOI · Paper page
  55. Silva, 2022, Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats, PLoS One, 17, 10.1371/journal.pone.0268434 · DOI
  56. Weingarten-Gabbay, 2022, HLA-I immunopeptidome profiling of human cells infected with high-containment enveloped viruses, STAR Protoc., 3, 10.1016/j.xpro.2022.101910 · DOI
  57. Ruiz Cuevas, 2021, Most non-canonical proteins uniquely populate the proteome or immunopeptidome, Cell Rep., 34, 10.1016/j.celrep.2021.108815 · DOI · Paper page
  58. Stewart, 2022, The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity, bioRxiv
  59. Ghosh, 2020, β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway, Cell, 183, 1520, 10.1016/j.cell.2020.10.039 · DOI · Paper page
  60. Chen, 2021, SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway, J. Virol., 95, 10.1128/JVI.00862-21 · DOI
  61. Gentili, 2023, ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling, Nat. Commun., 14, 611, 10.1038/s41467-023-36132-9 · DOI
  62. Abelin, 2023, Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues, Nat. Commun., 14, 1851, 10.1038/s41467-023-37547-0 · DOI
  63. Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 265, 10.1038/s41586-020-2008-3 · DOI · Paper page

Cited by

See all 17

Metadata

Authors
Weingarten-Gabbay, S., Chen, D.-Y., Sarkizova, S., Taylor, H. B., Gentili, M., Hernandez, G. M., Pearlman, L. R., Bauer, M. R., Rice, C. M., Clauser, K. R., Hacohen, N., Carr, S. A., Abelin, J. G., Saeed, M., & Sabeti, P. C.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2024-01
Volume
43
Issue
1
Pages
113596
ISSN
2211-1247
Cited by
17
References
15
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.